A drug for Alzheimer’s disease can also fight obesity, study finds
Over 40% of people in the U.S. are obese, according to the Centers for Disease Control and Prevention.
This figure is even higher in American...
These places in U.S. have the most cases of Alzheimer’s disease
There is a new study that tells us where Alzheimer's disease is most common in the United States.
It turns out that the East and...
Scientists find a new cause of Parkinson’s disease
Parkinson's disease affects around 8 million people worldwide.
This nervous system disorder mainly impacts movement, causing tremors, stiffness, and difficulties with balance and coordination.
For centuries,...
Hope for Alzheimer’s: A peek at drug Donanemab’s potential
Alzheimer's disease is a scary condition that affects the mind.
It can make people forget things, from little stuff like where they put their keys...
Dance training with music slows Parkinson’s progression, study suggests
A new study published in Brain Sciences shows that dance training with music can slow the progression of mild-to-moderate Parkinson's disease (PD).
Participants who engaged...
New blood test may predict Alzheimer’s risk decades prior to symptoms
A recent study suggests that certain proteins found in the blood could indicate an individual's risk of developing Alzheimer's disease up to 20 years...
A step towards equality: Scientists find how to predict Alzheimer’s across ethnicities
Alzheimer's disease is a severe health concern affecting one out of every ten individuals aged 65 and above, according to the U.S. Centers for...
Prebiotics: A new way to help treat Parkinson’s disease
Constipation is a common condition caused by a myriad of factors. However, it could be an early sign of Parkinson's disease, showing up to...
Muscle supplement could help battle Alzheimer’s, study finds
A team of researchers at RUSH recently discovered that a popular muscle-building supplement might also be a potent weapon against Alzheimer's disease.
The supplement, known...
Alzheimer’s drug donanemab has been hailed as a ‘turning point’ for treatment. But what...
Trial results of a new drug to treat Alzheimer’s disease, donanemab, shows it can slow cognitive decline by 35%. The drug has been hailed...